Intensity Therapeutics INTS
NASDAQ INTS
$3.42 -0.23 (-6.28%)
As of: Sep 29, 2026 · 3:55 PM EDT

Intensity Therapeutics (INTS) Preferred Dividend Payments (2023)

Updated

Intensity Therapeutics (INTS) recorded Preferred Dividend Payments of $1.32 million in FY2023.

Analysis

Intensity Therapeutics (INTS) Preferred Dividend Payments (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Intensity Therapeutics 10.75 Mn 10.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.32 Mn
API Access

Intensity Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=INTS&period=max&api_key=YOUR_API_KEY